GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Other Long-Term Liabilities

ACME Laboratories (DHA:ACMELAB) Other Long-Term Liabilities : BDT798 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Other Long-Term Liabilities?

ACME Laboratories's other long-term liabilities for the quarter that ended in Mar. 2024 was BDT798 Mil.

ACME Laboratories's quarterly other long-term liabilities declined from Jun. 2023 (BDT903 Mil) to Sep. 2023 (BDT861 Mil) and declined from Sep. 2023 (BDT861 Mil) to Mar. 2024 (BDT798 Mil).

ACME Laboratories's annual other long-term liabilities increased from Jun. 2021 (BDT874 Mil) to Jun. 2022 (BDT908 Mil) but then declined from Jun. 2022 (BDT908 Mil) to Jun. 2023 (BDT903 Mil).

ACME Laboratories Other Long-Term Liabilities Historical Data

The historical data trend for ACME Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Other Long-Term Liabilities Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Long-Term Liabilities
Get a 7-Day Free Trial - - - - -

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ACME Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

ACME Laboratories Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Other Long-Term Liabilities
Comparable Companies
DHA:ORIONINFU DHA:AFCAGRO DHA:BEACONPHAR DHA:BXPHARMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
Website
https://www.acmeglobal.com
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines